Home » Stocks » RKDA

Arcadia Biosciences, Inc. (RKDA)

Stock Price: $3.12 USD 0.19 (6.48%)
Updated November 24, 12:01 PM EST - Market open

Stock Price Chart

Key Info

Market Cap 33.80M
Revenue (ttm) 1.32M
Net Income (ttm) -19.80M
Shares Out 10.83M
EPS (ttm) -2.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 24
Last Price $3.12
Previous Close $2.93
Change ($) 0.19
Change (%) 6.48%
Day's Open 3.15
Day's Range 3.04 - 3.16
Day's Volume 245,379
52-Week Range 2.30 - 6.63

More Stats

Market Cap 33.80M
Enterprise Value 31.12M
Earnings Date (est) Mar 10, 2021
Ex-Dividend Date n/a
Shares Outstanding 10.83M
Float 9.16M
EPS (basic) -1.85
EPS (diluted) -2.12
FCF / Share -2.90
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 360,998
Short Ratio 2.74
Short % of Float 3.94%
Beta -0.63
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 25.60
PB Ratio 2.93
Revenue 1.32M
Operating Income -25.24M
Net Income -19.80M
Free Cash Flow -31.09M
Net Cash 2.68M
Net Cash / Share 0.25
Gross Margin -516.21%
Operating Margin -1,912.27%
Profit Margin -1,499.80%
FCF Margin -2,355.53%
ROA -39.11%
ROE -159.67%
ROIC -94.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$11.33*
(263.14% upside)
Low
10.0
Current: $3.12
High
12.0
Target: 11.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013
Revenue1.171.464.033.195.416.986.48
Revenue Growth-20.15%-63.64%26.29%-41.12%-22.46%7.78%-
Gross Profit0.280.803.742.294.524.995.81
Operating Income-21.09-19.43-14.32-18.62-15.56-15.15-10.57
Net Income-28.81-13.48-15.71-19.62-17.96-18.34-13.20
Shares Outstanding6.363.772.162.221.430.100.10
Earnings Per Share-4.53-3.58-7.28-8.85-14.60-214.20-128.60
Operating Cash Flow-17.20-13.63-13.97-17.06-15.11-14.79-9.75
Capital Expenditures-1.46-0.24-0.08-0.23-0.14-0.14-0.10
Free Cash Flow-18.66-13.87-14.04-17.29-15.25-14.93-9.85
Cash & Equivalents25.3321.8213.0250.5650.2416.572.84
Total Debt2.24--25.1324.9314.4814.49
Net Cash / Debt23.0921.8213.0225.4325.312.10-11.66
Assets32.5724.0216.5756.5774.2424.899.54
Liabilities24.2511.218.5634.3834.0226.7726.84
Book Value7.7112.828.0122.2040.23-84.77-17.30
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Arcadia Biosciences, Inc.
Country United States
Employees 41
CEO Matthew T. Plavan

Stock Information

Ticker Symbol RKDA
Stock Exchange NASDAQ
Sector Basic Materials
Industry Agricultural Inputs
Unique Identifier NASDAQ: RKDA
IPO Date May 15, 2015

Description

Arcadia Biosciences, a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; nutritional oils; and HB4, a drought and herbicide tolerant soybean trait. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Canada, Africa, and India. The company was founded in 2002 and is headquartered in Davis, California.